Form 4: Lemaitre Vascular Exec's Stock Transactions

Lemaitre Vascular's Senior VP of Operations, Trent G. Kamke, reported stock transactions related to RSU and PSU vesting, including tax-related share dispositions.

Summary

• Trent G. Kamke, Senior V.P., Operations at Lemaitre Vascular Inc. (LMAT), reported changes in beneficial ownership of common stock.
• On December 8, 2025, 4 shares of common stock were acquired upon the release of dividend equivalent rights related to a restricted stock unit (RSU) award.
• Also on December 8, 2025, 5 shares of common stock were acquired upon the release of dividend equivalent rights related to a performance stock unit (PSU) award.
• A total of 77 shares of common stock were disposed of on December 8, 2025, at a price of $82.93 per share, to satisfy tax withholding obligations incurred upon the vesting of RSUs granted on December 8, 2023.
• An additional 92 shares of common stock were disposed of on December 8, 2025, at a price of $82.93 per share, to satisfy tax withholding obligations incurred upon the vesting of PSUs granted on December 8, 2023.
• Following these transactions, beneficial ownership of common stock is 3,483 shares.

Sentiment

Score: 6

Explanation: The filing reports routine insider transactions related to the vesting of equity awards and subsequent tax-related share dispositions. While there's a net decrease in direct ownership due to tax withholding, the underlying vesting is a positive for the executive, making the overall sentiment neutral to slightly positive as it reflects standard compensation practices.

Positives

• The vesting of restricted stock units (RSUs) and performance stock units (PSUs) indicates the fulfillment of equity compensation terms, often tied to continued employment and company performance.

Negatives

• A net decrease in direct common stock ownership occurred due to the disposition of 169 shares (77 RSU-related + 92 PSU-related) to cover tax withholding obligations.

Future Outlook

This filing does not contain forward-looking statements or guidance, as it reports past insider transactions.

Industry Context

These transactions represent routine equity compensation events common across publicly traded companies, particularly in the medical device industry, where executive compensation often includes stock-based awards to align management interests with shareholder value.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) and performance stock units (PSUs) as part of executive compensation is a standard practice across various industries, including medical devices, to incentivize long-term performance and retention.
• The disposition of shares to cover tax withholding obligations upon the vesting of equity awards is a common and expected event for insiders receiving such compensation, aligning with tax regulations and company policies.

Stakeholder Impact

• Shareholders: These are routine insider transactions and do not typically have a significant direct impact on the company's operational or financial performance. They reflect standard executive compensation practices.
• Employees: The vesting of equity awards is a common component of executive compensation, aligning with broader compensation strategies within the company.

Key Dates

Recommendation

The filing details routine insider transactions related to the vesting of restricted and performance stock units and subsequent tax withholding. These are standard compensation events and do not provide new material information to alter an investment decision or suggest a change in the company's fundamental outlook.

Keywords

Lemaitre Vascular, LMAT, Form 4, insider trading, stock transactions, RSU vesting, PSU vesting, equity compensation, Trent G. Kamke, beneficial ownership